NCT06097169

Evaluation of the Postoperative Agitation Prevention and Analgesic Efficacy of Perioperative Dexmedetomidine Infusion in a Pediatric Patient Group to Undergo Dental Treatment

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 80 (actual)
• Sponsor: Medipol University · Academic / Other
• Sex: All
• Age: 2 Years – 10 Years
• Healthy volunteers: Not accepted

Summary

Dexmedetomidine is a drug known for its pain-relieving and restlessness-reducing effects. The purpose of this run is to use the association between this use during surgery and the attrition of post-operative pain and discomfort. In the research, laboratory and monitoring results will be obtained before, during and after the operation. Postoperative patient complaints will be evaluated at the postoperative service visit. This study is decided on a completely voluntary basis.

Conditions

• Anxiety
• Postoperative Pain
• Nausea

Interventions

Type	Name	Description
DRUG	Fentanyl	In Group dex, dexmedetomidine infusion will be administered to the patient during the operation. Fentanyl bolus dose will be administered during anesthesia induction in group Fen.
DRUG	Dexmedetomidine	In Group dex, dexmedetomidine infusion will be administered to the patient during the operation. Fentanyl bolus dose will be administered during anesthesia induction in group Fen.

Timeline

• Start date: 2023-10-10
• Primary completion: 2024-02-20
• Completion: 2024-02-25
• First posted: 2023-10-24
• Last updated: 2024-02-29

Locations

1 site across 1 country: Turkey (Türkiye)

Regulatory

• FDA-regulated drug study